Abstract
In this open label study we evaluated the efficacy of Levetiracetam (LEV) in the long-term treatment of 15 patients (7 males, 8 females, age range 4-40 years, mean 22.53 years) with drug-resistant symptomatic epilepsies. Our data showed that LEV is an efficacious and safe antieplleptic drug in this group of subjects.
Translated title of the contribution | Efficacy of Levetiracetam in the long-term treatment of drug-resistant symptomatic epilepsies |
---|---|
Original language | Italian |
Pages (from-to) | 197-199 |
Number of pages | 3 |
Journal | Bollettino - Lega Italiana contro l'Epilessia |
Issue number | 129-130 |
Publication status | Published - 2005 |
ASJC Scopus subject areas
- Clinical Neurology